These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13457)

  • 1. Stereoselectivity and affinity in molecular pharmacology.
    Lehmann PA
    Prog Drug Res; 1976; 20():101-42. PubMed ID: 13457
    [No Abstract]   [Full Text] [Related]  

  • 2. [A molecular basis for the action of drugs. I. Receptor-theory and structure-effect relations].
    Ariëns EJ
    Arzneimittelforschung; 1966 Nov; 16(11):1376-95. PubMed ID: 4386673
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and pharmacology of combined histamine H1-/H2-receptor antagonists containing diphenhydramine and cyproheptadine derivatives.
    Wolf C; Schunack W
    Arch Pharm (Weinheim); 1996 Feb; 329(2):87-94. PubMed ID: 8851472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histamine release by histamine controlled by H2 receptor.
    Lichtenstein LM; Gillespie E
    Nature; 1973 Aug; 244(5414):287-8. PubMed ID: 4126784
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current problems in drug research. I. Determination of the quantitative structure-activity relationships of biosubstances: theoretical principles, accomplishments, assumptions and present state].
    Franke R; Oehme P
    Pharmazie; 1973 Aug; 28(8):489-508. PubMed ID: 4131698
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-receptor antagonists.
    Levi R; Kuye JO
    Eur J Pharmacol; 1974 Aug; 27(3):330-8. PubMed ID: 4153866
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels.
    Kuo CC; Huang RC; Lou BS
    Mol Pharmacol; 2000 Jan; 57(1):135-43. PubMed ID: 10617688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of conformationally restricted antihistamines to histamine receptors.
    Ison RR; Franks FM; Soh KS
    J Pharm Pharmacol; 1973 Nov; 25(11):887-94. PubMed ID: 4149652
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic evaluation of a new series of cholinergic antagonists containing an agonist moiety.
    Hudgins PM; Stubbins JF
    J Pharmacol Exp Ther; 1969 Apr; 166(2):237-42. PubMed ID: 4388418
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformationally restricted analogs of histamine H1 receptor antagonists. Trans- and cis-1,5-Diphenyl-3-dimethylaminopyrrolidine.
    Hanna PE; Ahmed AE
    J Med Chem; 1973 Sep; 16(9):963-8. PubMed ID: 4147659
    [No Abstract]   [Full Text] [Related]  

  • 11. X-ray analytical reexamination of correlation of nitrogen lone-pair orientation with analgetic activity.
    Shiotani S; Kometani T; Iitaka Y; Itai A
    J Med Chem; 1978 Feb; 21(2):153-4. PubMed ID: 621711
    [No Abstract]   [Full Text] [Related]  

  • 12. A thermodynamic approach to problems of drug antagonism. Measurements of the parameters of affinity (pA2) of antihistaminics and a beta-haloalkylamine under varying experimental conditions.
    Rocha e Silva M; Fernandes F
    Eur J Pharmacol; 1974 Feb; 25(2):231-40. PubMed ID: 4154854
    [No Abstract]   [Full Text] [Related]  

  • 13. Conformationally restricted analogs of histamine H1 receptor antagonists. 2-Phenyl- and 2-benzyl-1,2,3,4-tetrahydro-4-dimethylaminoisoquinoline.
    Hanna PE; Grund VR; Anders MW
    J Med Chem; 1974 Sep; 17(9):1020-3. PubMed ID: 4153302
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist.
    Black JW; Durant GJ; Emmett JC; Ganellin CR
    Nature; 1974 Mar; 248(5443):65-7. PubMed ID: 4150456
    [No Abstract]   [Full Text] [Related]  

  • 15. H(1)- antihistamines and activated blood platelets.
    Petríková M; Jancinová V; Nosál R; Májeková M; Holománová D
    Inflamm Res; 2006 Apr; 55 Suppl 1():S51-2. PubMed ID: 16547813
    [No Abstract]   [Full Text] [Related]  

  • 16. A thermodynamic approach to problems of drug antagonism I. The "Charnière theory".
    Rocha e Silva
    Eur J Pharmacol; 1969; 6(3):294-302. PubMed ID: 4389945
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformationally restricted analogs of histamine H1 receptor antagonists: trans and cis-1-benzyl-3-dimethylamino-6-phenylpiperidine.
    Ahmed AE; Hanna PE; Grund VR
    J Med Chem; 1976 Jan; 19(1):117-22. PubMed ID: 1535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for histamine can be detected on the surface of selected leukocytes.
    Melmon KL; Bourne HR; Weinstein J; Sela M
    Science; 1972 Aug; 177(4050):707-9. PubMed ID: 4403369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.
    Carlson BB; Trevitt JT; Salamone JD
    Pharmacol Biochem Behav; 2000 Apr; 65(4):683-9. PubMed ID: 10764923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.